CXCR2 Antagonist Cpd 19 is a high-performance compound designed to regulate the biological activity of CXCR2. Renowned for its unique formulation, our compound delivers unprecedented results across multiple applications.
Boost your performance standards with CXCR2 Antagonist Cpd 19 as you unlock its numerous applications. Explore further MSRP, industry-trusted peer-reviewed papers, technical documents, and similar products on our website.
The CXCR2 Antagonist Cpd 19 is a potent agent renowned for revolutionizing the control of biological activity. Equipped with a unique composition and the CAS number 473728-67-5, the compound exhibits pronounced antagonistic properties against CXCR2, paving its importance in pharmaceutical and medical research domains.
Bearing the captivating molecular structure of 3-(2-(cyclopentylamino)-3,4-dioxocyclobut-1-enylamino)-2-hydroxy-N,N-dimethylbenzamide, the essence of Cpd 19 lies in its potential to control biological activity.
Being a multicellular utility, Cpd 19 displays potential applications in pharmaceutical research, drug development, investigations in immunology, cancer and oncology studies, and analyses in inflammation. It promises reliable outcomes, making it a valuable component across various research methods.
To ensure the safe handling of Cpd 19, wearing gloves and goggles, a cool and dry storage atmosphere, and a well-ventilated usage area are recommended. Always adhere to local regulations and safety guidelines along with MSDS for in-depth handling instructions.
For extensive details on Cpd 19, including MSDS, associated technical documents, peer-reviewed papers, and other relevant products, our website provides a complete range of CXCR2 antagonists and similar compounds ideal for your research needs.